𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specific Immunotherapy Using a Recombinant Vaccinia Virus Expressing Human Carcinoembryonic Antigen

✍ Scribed by JUDY KANTOR; SCOTT ABRAMS; KARI IRVINE; PHILIP SNOY; HOWARD KAUFMAN; JEFFREY SCHLOM

Book ID
119869551
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
201 KB
Volume
690
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A recombinant vaccinia virus expressing
A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): Safety and immunogenicity in a non-human primate
✍ James W. Hodge; Jeffrey Schlom; Susan J. Donohue; Joseph E. Tomaszewski; Clyde W πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 915 KB

Prostate-specific antigen (PSA) is a serine protease secreted by prostatic epithelial cells and is widely used as a marker for prostate cancer. The tissue specificity of PSA makes it a potential target for active specific immunotherapy, especially in prostate cancer patients who have undergone prost

Phase I immunotherapy with a modified va
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
✍ Professor Christoph Rochlitz; Robert Figlin; Patrick Squiban; Marc Salzberg; Mik πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract ## Background The MUC1 protein is a highly glycosylated mucin normally found at the apical surface of mucin‐secreting epithelial cells in many types of tissues. MUC1 is expressed, but heavily underglycosylated, in different human tumors. TG4010 is a viral suspension of a recombinant va